Nevada Sunrise Metals (TSXV:NEV,OTCP:NVSGF) is a Nevada-focused exploration company with a portfolio spanning gold, copper and lithium projects. Nevada ranked as the world’s second most attractive exploration jurisdiction in 2024, providing a strong foundation for the company’s growth strategy.

The Griffon Gold Mine project, a past-producing gold asset located within the prolific Battle Mountain–Eureka Trend. Griffon hosts Carlin-type mineralization, produced 62,661 ounces of oxide gold from 1998 to 1999, and benefits from extensive historical drilling, favorable host stratigraphy and new target zones identified by VRIFY’s DORA A.I. predictive modeling. Ongoing geophysics and geochemical programs in 2025 will refine drill targets ahead of a drilling program planned for 2026.

Nevada Sunrise integrates historical data with advanced geophysics, modern geochemical methods, and AI-driven exploration tools. This technology-enhanced approach, combined with experienced leadership and a strong technical team, is central to the Company’s strategy for building shareholder value.

Company Highlights

• Flagship past-producing gold project in a Tier-1 jurisdiction: The Griffon Gold Mine project lies within Nevada’s prolific Battle Mountain–Eureka Trend, near producing mines and major gold developers.
• AI-powered exploration strategy: Nevada Sunrise is using VRIFY’s predictive modeling to identify high-priority drill targets, an emerging technology rarely applied in Nevada.
• Clear path to 2026 drilling: Soil, magnetic, IP/resistivity and CSAMT surveys in fall 2025 will feed into an updated AI model, enabling optimized drill targeting planned for 2026.
• Highly experienced management and geological team: Leadership includes executives and advisors with decades of exploration success across Nevada and globally.
• Diversified asset portfolio: Gold, copper and lithium assets create optionality across multiple mineral markets.
• Flagship past-producing gold project in a Tier-1 jurisdiction: The Griffon Gold Mine project lies within Nevada’s prolific Battle Mountain–Eureka Trend, near producing mines and major gold developers.
• AI-powered exploration strategy: Nevada Sunrise is using VRIFY’s predictive modeling to identify high-priority drill targets, an emerging technology rarely applied in Nevada.
• Clear path to 2026 drilling: Soil, magnetic, IP/resistivity and CSAMT surveys in fall 2025 will feed into an updated AI model, enabling optimized drill targeting planned for 2026.
• Highly experienced management and geological team: Leadership includes executives and advisors with decades of exploration success across Nevada and globally.
• Diversified asset portfolio: Gold, copper and lithium assets create optionality across multiple mineral markets.

This Nevada Sunrise Metals profile is part of a paid investor education campaign.*

Click here to connect with Nevada Sunrise Metals (TSXV:NEV) to receive an Investor Presentation

Big Pharma ETFs

Many of these funds have diverse holdings across some of the most important sectors in the pharmaceutical industry, including pain therapeutics, oncology, vaccines and biotechnology. Data was gathered on November 20, 2025.

1. VanEck Pharmaceutical ETF (NASDAQ:PPH)

Total assets under management: US$1.15 billion

Established in late 2011, the VanEck Pharmaceutical ETF tracks the MVIS US Listed Pharmaceutical 25 Index. It has the capacity to provide big returns, even though there are some risks attached to the ETF. An analyst report indicates that investors looking for ‘tactical exposure’ to the pharma sector might consider this ETF as an investment option.

The ETF has 26 holdings, with the top five being Eli Lilly (NYSE:LLY), Novartis (NYSE:NVS), Merck & Company (NYSE:MRK), Novo Nordisk (NYSE:NVO) and the McKesson (NYSE:MCK).

2. iShares US Pharmaceuticals ETF (ARCA:IHE)

Total assets under management: US$669.2 million

Created on May 5, 2006, the iShares US Pharmaceuticals ETF tracks some of the top US pharma companies. In total, the iShares US Pharmaceuticals ETF has 45 holdings, with the vast majority being large-cap stocks.

Of its holdings, Johnson & Johnson (NYSE:JNJ) and Eli Lilly are by far the largest portions in its portfolio, combining for nearly 50 percent, followed by Merck, Royalty Pharma (NASDAQ:RPRX) and Viatris (NASDAQ:VTRS).

3. Invesco Pharmaceuticals ETF (ARCA:PJP)

Total assets under management: US$299.48 million

The Invesco Pharmaceuticals ETF is primarily focused on providing exposure to US-based pharma companies. An analyst report states that this ETF chooses individual securities based on certain investment criteria, namely stock valuation and risk factors.

This ETF was started on June 23, 2005, and currently tracks 31 companies. Its top holdings are Eli Lilly, Amgen (NASDAQ:AMGN), Johnson & Johnson, Merck and AbbVie (NYSE:ABBV).

4. State Street SPDR S&P Pharmaceuticals ETF (ARCA:XPH)

Total assets under management: US$189.93 million

The State Street SPDR S&P Pharmaceuticals ETF came into the market on June 19, 2006, and represents the pharmaceutical sub-industry sector of the S&P Total Market Index (INDEXSP:SPTMI).

This pharma ETF tracks 52 holdings, with relatively close weighting among its holdings, a fact that sets it apart from other entries on this list. XPH’s top five holdings are Jazz Pharmaceuticals (NASDAQ:JAZZ), Tarsus Pharmaceuticals (NASDAQ:TARS), Eli Lilly, Ligand Pharmaceuticals (NASDAQ:LGND), and Crinetics Pharmaceuticals (NASDAQ:CRNX).

5. KraneShares MSCI All China Health Care Index ETF (ARCA:KURE)

Total assets under management: US$95.29 million

The KraneShares MSCI All China Health Care Index ETF was launched in February 2018 and tracks an index of large- and mid-cap Chinese stocks in the healthcare sector, all weighted by market capitalization. According to an analyst report, the fund provides investors with ‘exposure to a relatively small slice of the Chinese economy.’

The ETF tracks 50 holdings, and its top five are BeOne Medicines (NASDAQ:ONC), Jiangsu Hengrui Medicine (SHA:600276), Innovent Biologics (HKEX:1801), WuXi Biologics (HKEX:2269) and Sino Biopharmaceutical (HKEX:1177).

Global battery energy storage system deployment, 2022 to 2025.

Photo via Georgia Williams.

In the US, the trend is even more pronounced.

“We’re expecting energy storage to account for 35 to 40 percent of battery demand in the US in the next few years,” Hughes told the audience at the California-based conference. That shift is reshaping the supply chain, chemistry choices and the strategic priorities of both policymakers and manufacturers.

LFP chemistry takes center stage

The rise of utility-scale storage has in many respects become the story for lithium iron phosphate (LFP) chemistry.

LFP’s lower cost, strong performance profile and “dominance … on behalf of the innovation we’ve seen in LFP cells over the last few years” make it the chemistry of choice, Hughes said.

The cost advantage of LFP batteries is especially significant at a moment when policymakers are tightening sourcing standards and examining supply chains for vulnerabilities. Add to that the supply chain complexities associated with nickel, cobalt and manganese (NCM) chemistries and the LFP segment again stands out.

Despite rapid deployment, grid storage remains highly concentrated, with China and the US together representing 87 percent of all global installations to date. But that dominance may be tested sooner than expected.

Hughes pointed to Saudi Arabia, which “a year ago wasn’t even on this chart,” yet deployed 11 gigawatt hours of storage in just the first three months of this year. “It really goes to show just how early this market is,” she said.

New regions can move from nonexistent to major players “in a matter of months.”

That acceleration is directly linked to plunging costs.

Fully integrated storage systems in China are now sold below US$100 per kilowatt-hour, a milestone that dramatically strengthens project economics, even in environments where subsidies or tax supports have been reduced.

US energy storage market booming

Storage deployment in the US continues to surge, led by California, Texas, Arizona, Nevada and New Mexico.

New Mexico’s rise is particularly telling, according to Hughes.

“New Mexico being the fifth largest state … is just two or three projects,” she noted. That underscores just how early the US storage market still is, and how quickly major projects can reshape state-level capacity.

Hughes also said very large installations are becoming increasingly central. Benchmark defines “giga-scale” projects as those exceeding 1 gigawatt hour, once an industry novelty. Now they are transforming demand patterns.

“This year, we’re expecting nine of these to come online, accounting for 20 percent of battery demand,” Hughes said. By next year, 21 more are in the pipeline, accounting for nearly 40 percent of expected demand.

However, the US policy landscape is shifting. The Inflation Reduction Act’s investment tax credit remains intact for storage, but now comes with stricter sourcing rules for both cells and systems.

That has triggered a rush to secure US-eligible supply, particularly for LFP. The number of announced LFP gigafactories jumped 61 percent between January and November of this year.

Much of that new capacity is being driven by Korean manufacturers such as LG Electronics (KRX:066570), SK Innovation (KRX:096770) and Samsung Electronics (KRX:005930,OTC Pink:SSNLF).

Even so, manufacturers still face a major challenge in qualifying for the Section 45X production tax credit as cathode and precursor supply remains heavily dependent on China.

“That is definitely the biggest pinch point right now for the energy storage sector,” Hughes said.

Electricity demand set to surge in the US

The storage boom is tied to a deeper structural shift: electricity demand is rising after 15 years of stagnation.

Since the 2008 financial crisis, US electricity demand has been “basically flat,” Hughes said, as a result of offshored manufacturing and limited grid investment. But that stagnation is ending as artificial intelligence (AI) data centers, electrified heating, electric vehicle adoption and reshored industrial capacity drive consumption sharply higher.

Benchmark now expects 20 to 30 percent growth in US electricity demand by 2030. That surge “has very strong implications for the grid, for energy security,” Hughes noted, and puts storage “at the center of that conversation.”

Large language models and AI hyperscalers are quickly becoming a dominant force. While data centers have existed for decades, the new generation requires far greater power — and, increasingly, on-site battery storage.

“These large projects are the ones that are going to be having high requirements for batteries” in the coming years, Hughes said, with the US positioned as the global epicenter of AI-driven load growth.

Beyond LFP: The next storage frontier

Looking ahead, chemistry innovation will shape how storage supports the grid at different durations.

LFP is expected to remain the clear winner in four hour applications, while sodium-ion compositions could emerge as a disruptor in the same range. Between four and 10 hours, LFP is increasingly pushing out technologies like flow batteries and sodium-sulfur batteries due to cost advantages. Beyond 10 hours, a new suite of technologies is still in development, with US companies particularly active in that long-duration space.

As Hughes concluded, the role of storage is only growing.

With electricity demand accelerating and policy tightening, battery systems have moved from a peripheral technology to a strategic necessity, and the global energy transition is quickly reshaping around them.